Latest News about Briefs
Recent news which mentions Briefs
Marin Software Stock Jumps On Reddit, X Integration: Details
August 09, 2024
From Benzinga
What's Going On With Trump Media Stock On Friday?
August 09, 2024
From Benzinga
AMC Networks Takes $97M Impairment Hit In Q2, Reaffirms Strong Free Cash Flow Outlook
August 09, 2024
From Benzinga
Asia Markets Mixed, Europe Opens In Green; Gold Trades Near All-Time High - Global Markets Today While US Slept
August 09, 2024
From Benzinga
From Benzinga
Delta Bleeds Money After Tech Disaster, Pursues Legal Claims Against CrowdStrike And Microsoft
August 09, 2024
From Benzinga
Penny Stock Citius Pharmaceuticals Secures Its First FDA Approval For Skin Cancer Drug A Year After FDA Rejection
August 08, 2024
From Benzinga
AI-Powered Drug Discovery Firm Exscientia To Merge With Nvidia-Partner Recursion Pharmaceuticals
August 08, 2024
From Benzinga
Celsius Holdings Downgraded: Analyst Cautions Weak Consumer Environment, No Meaningful Recovery Projected Until Summer 2025
August 08, 2024
From Benzinga
What's Going On With ChargePoint Stock Today?
August 08, 2024
From Benzinga
From Benzinga
US Drugmaker Viatris Q2 Earnings Edge Out Analysts Expectation On Strong Demand For Branded And Generic Drugs
August 08, 2024
From Benzinga
Six Flags Reports Mixed Q2 Results: Cedar Fair Hits Records While Legacy Six Flags Attendance Faces Decline
August 08, 2024
From Benzinga
Enphase Boosts EV Charger Game with NACS Connectors For IQ EV Chargers, Says Compatible With Tesla
August 08, 2024
From Benzinga
Apellis Pharmaceuticals' Pegcetacoplan Meets Primary Goal In Late-Stage Study In Patients With Rare Kidney Diseases
August 08, 2024
From Benzinga
Hanesbrands Soars 14% After Q2 Earnings: Strength In US Innerwear Unit And Margin Gains Drive Upbeat Performance
August 08, 2024
From Benzinga
From Benzinga
From Benzinga
Aldeyra's New Eye Drug Shows Positive Results In FDA-Approved Study, Stock Jumps Over 30%
August 08, 2024
From Benzinga
Sanofi's Approved Blood Cancer Drug Sarclisa Shows Improved Progression-Free Survival In Patients Eligible For Transplant
August 08, 2024
From Benzinga
From Benzinga
GoodRx Reports Q2 Earnings With Increased Prescription Revenue But Subscription Challenges
August 08, 2024
From Benzinga
Merck Stops Lung Cancer Study For Keytruda Combo Due To Ineffective Results, Side Effects
August 08, 2024
From Benzinga
Burger King Parent Restaurant Brands Gains After Q2 Results - Revenue Shines Amid Bold Future Plans
August 08, 2024
From Benzinga
CyberArk Software Q2: Revenue Jumps 28% With Strong Subscription Growth, 2024 Outlook Raised
August 08, 2024
From Benzinga
From Benzinga
Apple's Satellite Connectivity Provider Globalstar's Q2 Revenue Grows 10% On Wholesale Capacity Surge, Hikes FY24 Outlook
August 08, 2024
From Benzinga
From Benzinga
US Foods Q2: Sales Beat, Reiterated FY24 Outlook & More
August 08, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.